Evidence map›Paper›PMID 36192736›Full record

ArticleHarm reduction journal2022

'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.

Matthew R Filteau, Brandn Green, Frances Kim, Ki-Ai McBride

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew R FilteauJG Research and Evaluation, Bozeman, MT, USA. matthew@jgresearch.org.
Brandn GreenJG Research and Evaluation, Bozeman, MT, USA.
Frances KimJG Research and Evaluation, Bozeman, MT, USA.
Ki-Ai McBrideMontana Department of Health and Human Services, Behavioral Health and Disabilities Disorders Division, Helena, MT, USA.
Montana Department of Public Health and Human Services · US

Funding

SAMHSA HHS 6H79TI081722-02M004
6 · The paper itself

Abstract

The Substance Abuse and Mental Health Services Administration's (SAMHSA) Harm Reduction grant program expanded access to several harm reduction strategies to mitigate opioid overdose fatalities, including expanding access to naloxone. Interviews with first responders in a frontier and remote (FAR) state were conducted to understand their job responsibilities in relation to overdose response and prevention and their perceptions of training laypersons to administer naloxone. This study includes 22 interviews with law enforcement, EMS and/or fire personnel, and members of harm reduction-focused community organizations. The study finds widespread support for increasing access to naloxone and training laypersons in naloxone administration throughout Montana, due to rural first responders' inability to meet the needs of residents and an overall lack of resources to address addiction and the effects of fentanyl. Participants from harm reduction-focused community organizations convey support for training lay persons, but also illuminate that real and perceived cultural opposition to harm reduction strategies could reduce the likelihood that laypeople enroll in naloxone training. This study adds to the literature because it focuses on first responders in a FAR area that would benefit from layperson naloxone education and administration training due to its geographic expansiveness and the area's overall lack of access to medications for opioid use disorder or other treatment services. Expanding harm reduction approaches, like increasing access and training laypersons to administer naloxone, might be FAR residents' best chance for surviving an opioid overdose.

Indexed as

Cardiopulmonary ResuscitationDrug OverdoseEmergency RespondersOpiate OverdoseOpioid-Related DisordersAnalgesics, OpioidFentanylHumansNaloxoneNarcotic AntagonistsAnalgesics, OpioidFentanylNaloxoneNarcotic AntagonistsFrontier and Remote (FAR)Harm ReductionLayperson Training and AdministrationNaloxone

Identifiers

PMID36192736
PMCPMC9531424
OpenAlexW4300860906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.